Large-scale testing (Phase 3)Study completedNCT00301366
What this trial is testing
The Safety and Tolerability of Alpha-1 Modified Process (MP) In Subjects With Alpha-1-antitrypsin (AAT) Deficiency
Who this might be right for
Alpha 1-Antitrypsin Deficiency
Grifols Therapeutics LLC 38